5526 - 5550 of 9030 Results
Title
Year
-
OPENTitle: Does Prefrontal Glutamate Index Cognitive Changes in Parkinson’s Disease?Journal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page: 809905End Page: 809905Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2022.809905Best OA location URL: https://doi.org/10.3389/fnhum.2022.809905Citation Count: 9
- Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Randomization Approach2021OPENTitle: Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Randomization ApproachJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2264End Page: 2272Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28760Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8530889Citation Count: 46
-
OPENTitle: Impairment of neuronal activity occurs at the early stages of the aggregation cascade of Aβ1-42 and mutant TauJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 19Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.052295Best OA location URL: https://doi.org/10.1242/dmm.052295Citation Count: 0
- Reply to: “Biomarker‐Based Corticobasal Syndrome Classification: The Added Value of Deep Phenotyping and Population Diversity”2026RESTRICTEDTitle: Reply to: “Biomarker‐Based Corticobasal Syndrome Classification: The Added Value of Deep Phenotyping and Population Diversity”Journal Name: Movement DisordersPublisher: WileyVol: 41Issue #: 5Start Page: 1326End Page: 1327Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.70306Citation Count: 0
-
OPENTitle: LRP1: a novel receptor for the transmission of pathological α-SynucleinJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page: 79End Page: 79Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-022-00582-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-022-00582-4Citation Count: 6
-
RESTRICTEDTitle: Sex, Age, and Emotional Valence: Revealing Possible Biases in the ‘Reading the Mind in the Eyes’ TaskJournal Name: Frontiers in PsychologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page: 570End Page: 570Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fpsyg.2018.00570Best OA location URL: https://www.frontiersin.org/articles/10.3389/fpsyg.2018.00570/pdfCitation Count: 3
- RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8A2018OPENTitle: RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8AJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page: 417End Page: 417Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2018.00417Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2018.00417/pdfCitation Count: 45
- Partnering With Participant Advisors on the Parkinson's Progression Markers Initiative2026RESTRICTEDTitle: Partnering With Participant Advisors on the Parkinson's Progression Markers InitiativeJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78220Citation Count: 0
-
OPENTitle: Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegenerationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 116Issue #: 12Start Page: 5765End Page: 5774Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1814909116Best OA location URL: https://www.pnas.org/content/pnas/116/12/5765.full.pdfCitation Count: 124
-
OPENTitle: Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesiaJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 115Issue #: 3Start Page: 1713End Page: 1729Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00868.2015Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4809970Citation Count: 26
-
OPENTitle: Hypoxic conditioning in Parkinson’s disease: randomized controlled multiple N-of-1 trialsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page: 8469End Page: 8469Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-025-63324-2Best OA location URL: https://www.nature.com/articles/s41467-025-63324-2.pdfCitation Count: 3
-
OPENTitle: LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic miceJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 28End Page: 28Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-019-0679-5Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-019-0679-5Citation Count: 48
-
RESTRICTEDTitle: Design, synthesis, and in vitro evaluation of quinolinyl analogues for α-synuclein aggregationJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 28Issue #: 6Start Page: 1011End Page: 1019Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.bmcl.2018.02.031Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5870887Citation Count: 18
- Brain and gut: Partners in crime2018RESTRICTEDTitle: Brain and gut: Partners in crimeJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 7Start Page: 1098End Page: 1098Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27407Citation Count: 1
-
OPENTitle: Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X MouseJournal Name: BiomedicinesPublisher: MDPI AGVol: 9Issue #: 5Start Page: 514End Page: 514Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biomedicines9050514Best OA location URL: https://www.mdpi.com/2227-9059/9/5/514/pdf?version=1620466923Citation Count: 6
- P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteers2012RESTRICTEDTitle: P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteersJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 8Issue #: 4S_Part_3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2012.05.296Citation Count: 0
-
OPENTitle: Assessing Visuospatial Skills in Parkinson's: Comparison of Neuropsychological Assessment Battery Visual Discrimination to the Judgment of Line OrientationJournal Name: Archives of Clinical NeuropsychologyPublisher: Oxford University Press (OUP)Vol: 32Issue #: 1Start Page: 123End Page: 127Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/arclin/acw102Best OA location URL: https://academic.oup.com/acn/article-pdf/32/1/123/9951631/acw102.pdfCitation Count: 4
- Quantification of blood–brain barrier transport and neuronal toxicity of unlabelled multiwalled carbon nanotubes as a function of surface charge2019RESTRICTEDTitle: Quantification of blood–brain barrier transport and neuronal toxicity of unlabelled multiwalled carbon nanotubes as a function of surface chargeJournal Name: NanoscalePublisher: Royal Society of Chemistry (RSC)Vol: 11Issue #: 45Start Page: 22054End Page: 22069Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1039/c9nr02866hCitation Count: 45
- Protection from cyanide‐induced brain injury by the Nrf2 transcriptional activator carnosic acid2015OPENTitle: Protection from cyanide‐induced brain injury by the Nrf2 transcriptional activator carnosic acidJournal Name: Journal of NeurochemistryPublisher: WileyVol: 133Issue #: 6Start Page: 898End Page: 908Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.13074Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13074Citation Count: 62
-
OPENTitle: 14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shorteningJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 25Issue #: 1Start Page: 109End Page: 122Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddv453Best OA location URL: https://academic.oup.com/hmg/article-pdf/25/1/109/7145789/ddv453.pdfCitation Count: 84
-
OPENTitle: Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitorsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.17111Best OA location URL: https://doi.org/10.7554/elife.17111Citation Count: 55
-
OPENTitle: Unfolded protein response markers Grp78 and eIF2alpha are upregulated with increasing alpha‐synuclein levels in Lewy body diseaseJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 50Issue #: 4Start Page: e12999End Page: e12999Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/nan.12999Best OA location URL: https://doi.org/10.1111/nan.12999Citation Count: 9
-
OPENTitle: Striatal shape alteration as a staging biomarker for Parkinson’s DiseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 27Issue #:Start Page: 102272End Page: 102272Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2020.102272Best OA location URL: https://doi.org/10.1016/j.nicl.2020.102272Citation Count: 9
-
OPENTitle: Coordinated reset vibrotactile stimulation shows prolonged improvement in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 1Start Page: 179End Page: 180Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27223Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27223Citation Count: 40
-
OPENTitle: Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s diseaseJournal Name: Molecular Therapy - Nucleic AcidsPublisher: Elsevier BVVol: 28Issue #:Start Page: 1End Page: 15Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2022.02.007Best OA location URL: https://doi.org/10.1016/j.omtn.2022.02.007Citation Count: 25